Novel single-entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient-reported comfort.

Autor: Wan J; Asia Pacific Aesthetic Academy, Hong Kong, Hong Kong., Kim JS; Kimjongseo Plastic Surgery Clinic, Seoul, South Korea., Park Y; Obliv Clinic, Incheon, South Korea., Park SY; Made-Young Plastic Surgery Clinic, Seoul, South Korea., Koppert E; Department of Surgery, Epworth Hawthorn and Epworth Eastern Private Hospitals, Melbourne, Victoria, Australia., Kim HJ; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea., Yi KH; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.; Maylin Clinic (Apgujeong), Seoul, South Korea.
Jazyk: angličtina
Zdroj: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Nov; Vol. 23 (11), pp. 3539-3543. Date of Electronic Publication: 2024 Jul 15.
DOI: 10.1111/jocd.16461
Abstrakt: Introduction: Botulinum neurotoxin (BoNT) injections are widely used for the treatment of masseter muscle hypertrophy in Southeast Asia. However, there remains a lack of consensus regarding the optimal injection technique. This study aimed to compare the efficacy and patient discomfort associated with single-entry point injections versus multiple three-point injections for masseter muscle hypertrophy treatment with BoNT.
Materials and Methods: Sixteen participants, comprising both male and female Korean adults aged 22-63, were enrolled in the study. On the left side of the face, single-entry point injections were administered, followed by multidirectional injections, while on the right side, three-point injections were given. Pain intensity during the procedure was assessed using visual analogue scale scores.
Result: Our results revealed that participants experienced lower levels of pain with single-entry point injections compared to three-point injections (average visual analogue scores of 3.31 and 5.19, respectively).
Conclusion: These findings highlight the potential benefits of single-entry point injections in reducing patient discomfort during masseter muscle hypertrophy treatment with BoNT. We advocate for further research to validate these findings and encourage practitioners to consider single-entry point injections as a viable option for enhancing treatment outcomes in their clinical practice.
(© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje